| Hepatoprotective role for ERMP1 in MASLD-driven hepatocarcinogenesis and β-catenin-mutated tumors | Cancer letters |  | | 2026 | 31 | 118 |
|
| MicroRNAs as Regulators of Hepatic Metabolism and Carcinogenesis | |  | | 2026 | 16 | 2 |
|
| Paracellular transport along the nephron in physiology and pathophysiology | Current opinion in nephrology and hypertension |  | | 2026 | 26 | 0 |
|
| S100A10-ANXA2 tetramer inhibition hampers hepatic stellate cell activation in human MASLD organoids | EMBO molecular medicine |  | | 2026 | 10 | 21 |
|
| The enigma of ENaC activation by proteolytic cleavage: a never ending quest ? | Pflügers Archiv |  | | 2025 | 57 | 0 |
|
| Comparative analysis of S100A10 and S100A11 in MASLD and hepatic cancer development revealed a tumor suppressive role for S100A10 | Cell death and disease |  | | 2025 | 58 | 28 |
|
| ERMP1 as a newly identified ER stress gatekeeper in chronic kidney disease | American journal of physiology. Renal physiology |  | | 2025 | 131 | 190 |
|
| Hepatic IR and IGF1R signaling govern distinct metabolic and carcinogenic processes upon PTEN deficiency in the liver | JHEP reports |  | | 2025 | 145 | 344 |
|
| Hepatic miR-149-5p upregulation fosters steatosis, inflammation and fibrosis development in mice and in human liver organoids | JHEP reports |  | | 2024 | 102 | 148 |
|
| Endoplasmic reticulum stress in renal cell carcinoma | International journal of molecular sciences |  | | 2023 | 175 | 371 |
|
| TIA1 loss exacerbates fatty liver disease but exerts a dual role in hepatocarcinogenesis | Cancers |  | | 2022 | 295 | 434 |
|
| S100 proteins in fatty liver disease and hepatocellular carcinoma | International journal of molecular sciences |  | | 2022 | 335 | 163 |
|
| MiR-22 deficiency fosters hepatocellular carcinoma development in fatty liver | Cells |  | | 2022 | 279 | 322 |
|
| Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis | Cancers |  | | 2021 | 266 | 567 |
|
| Tristetraprolin promotes hepatic inflammation and tumor initiation but restrains cancer progression to malignancy | Cellular and Molecular Gastroenterology and Hepatology |  | | 2020 | 295 | 281 |
|
| Genetic ablation of MiR-22 fosters diet-induced obesity and NAFLD development | Journal of Personalized Medicine |  | | 2020 | 365 | 218 |
|
| mRNA post-transcriptional regulation by AU-rich element-binding proteins in liver inflammation and cancer | International Journal of Molecular Sciences |  | | 2020 | 370 | 110 |
|
| Deciphering miRNAs' action through miRNA editing | International Journal of Molecular Sciences |  | | 2019 | 248 | 291 |
|
| miRNAs and NAFLD: from pathophysiology to therapy | Gut |  | | 2019 | 443 | 2,701 |
|